1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Locally Advanced: new trials by email Literature Review of Locally Advanced trials Research Report on Locally Advanced
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study Pegfilgrastim, Placebo, Bevacizumab - Cancer, Colon Cancer | Phase 3 | Completed | Amgen | 847 | 2009-11-03 | 2017-12-29 |
Colonic Neoplasms (1) · Colorectal Neoplasms (1) · Febrile Neutropenia (1) · Fever (1) · Neoplasms (1) · Neutropenia (1) · Rectal Neoplasms (1)
Agranulocytosis (1) · Body Temperature Changes (1) · Colonic Diseases (1) · Cytopenia (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Intestinal Diseases (1) · Intestinal Neoplasms (1) · Leukocyte Disorders (1) · Leukopenia (1) · Neoplasms by Site (1)
Bevacizumab (1) · pegfilgrastim (1)
Amgen (1)
Australia (1) · Belgium (1) · Bulgaria (1) · Canada (1) · Czechia (1) · France (1) · Hungary (1) · Ireland (1) · Italy (1) · Latvia (1) · Mexico (1) · Poland (1) · Romania (1) · Russia (1) · Slovakia (1)